Jie Yu

A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix

Tingguo Zhang, Xiaofang Zhang, Jiannan Liu, 2020, Diagnostic Pathology.

Self-amplification of oxidative stress with tumour microenvironment-activatable iron-doped nanoplatform for targeting hepatocellular carcinoma synergistic cascade therapy and diagnosis

Yongzhong Du, Yuanfei Lu, R. Yu, 2021, Journal of Nanobiotechnology.

GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death

Chang-Jiun Wu, Xu Zhang, Rutong Yu, 2021, Cell Death & Disease.

MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways

Jun Liang, Xu Zhang, Rutong Yu, 2020, Frontiers in Oncology.

Csnk1a1 inhibition modulates the inflammatory secretome and enhances response to radiotherapy in glioma

Xu Zhang, Rutong Yu, Xuejiao Liu, 2021, Journal of cellular and molecular medicine.

GRP78 blockade overcomes intrinsic resistance to UBA1 inhibitor TAK-243 in glioblastoma

Xu Zhang, Rutong Yu, Xuejiao Liu, 2022, Cell death discovery.